The tumor suppressor function of ACE2 has been investigated in lung cancer [38,39], pancreatic cancer [40], Colon cancer [41] including breast cancer [36] however the cellular consequences of its silencing in different breast cancer subtypes remain to be investigated. This evidence concerns the gene ACE2 and lung carcinoma.